Validation of novel imaging methodologies for use as cancer clinical trial end-points Fulltext Access 10 Pages 2009
Restoration of tumour suppressor hsa-miR-145 inhibits cancer cell growth in lung adenocarcinoma patients with epidermal growth factor receptor mutation Fulltext Access 10 Pages 2009
Characterisation of gene expression profiles of yeast cells expressing BRCA1 missense variants Fulltext Access 10 Pages 2009
Estimation of an optimal chemotherapy utilisation rate for head and neck carcinoma: Setting an evidence-based benchmark for the best-quality cancer care Fulltext Access 10 Pages 2009
The effect of omega-3 FAs on tumour angiogenesis and their therapeutic potential Fulltext Access 10 Pages 2009
Molecular pharmacodynamics of PM02734 (elisidepsin) as single agent and in combination with erlotinib; synergistic activity in human non-small cell lung cancer cell lines and xenograft models Fulltext Access 10 Pages 2009
Treatment of advanced hepatocellular carcinoma with long-acting octreotide: A phase III multicentre, randomised, double blind placebo-controlled study Fulltext Access 10 Pages 2009
The influence of menopausal hormone therapy on tumour characteristics and survival in endometrial cancer patients Fulltext Access 10 Pages 2009
Meta-analysis of risk factors for cutaneous melanoma according to anatomical site and clinico-pathological variant Fulltext Access 10 Pages 2009
Clinical and psychometric validation of the EORTC QLQ-CR29 questionnaire module to assess health-related quality of life in patients with colorectal cancer Fulltext Access 10 Pages 2009
QUOTEchemo: A patient-centred instrument to measure quality of communication preceding chemotherapy treatment through the patient’s eyes Fulltext Access 10 Pages 2009
Salvage radiotherapy in patients with persisting/rising PSA after radical prostatectomy for prostate cancer Fulltext Access 10 Pages 2009
The launch of Cancer Research UK’s ‘Reduce the Risk’ campaign: Baseline measurements of public awareness of cancer risk factors in 2004 Fulltext Access 10 Pages 2009
Functional activity of CXCL8 receptors, CXCR1 and CXCR2, on human malignant melanoma progression Fulltext Access 10 Pages 2009
Ethidium bromide as a vital probe of mitochondrial DNA in carcinoma cells Fulltext Access 10 Pages 2009
Health and persistent functional late effects in adult survivors of childhood CNS tumours: A population-based cohort study Fulltext Access 10 Pages 2009
Current perspective: Bevacizumab in colorectal cancer - A time for reappraisal? Fulltext Access 10 Pages 2009
Cell cycle and apoptotic effects of SAHA are regulated by the cellular microenvironment in HCT116 multicellular tumour spheroids Fulltext Access 10 Pages 2009
Target-driven exploratory study of imatinib mesylate in children with solid malignancies by the Innovative Therapies for Children with Cancer (ITCC) European Consortium Fulltext Access 10 Pages 2009
Targeting of tamoxifen to enhance antitumour action for the treatment and prevention of breast cancer: The 'personalised' approach? Fulltext Access 10 Pages 2009
Positive association between nuclear Runx2 and oestrogen-progesterone receptor gene expression characterises a biological subtype of breast cancer Fulltext Access 10 Pages 2009
Mucin overexpression limits the effectiveness of 5-FU by reducing intracellular drug uptake and antineoplastic drug effects in pancreatic tumours Fulltext Access 10 Pages 2009
Aromatase inhibitor-associated bone loss in breast cancer patients is distinct from postmenopausal osteoporosis Fulltext Access 10 Pages 2009
Ethical and juridical issues of genetic testing: A review of the international regulation Fulltext Access 10 Pages 2009
Renal insufficiency and anticancer drugs in elderly cancer patients: A subgroup analysis of the IRMA study Fulltext Access 10 Pages 2009
Current management of stage I testicular non-seminomatous germ cell tumours Fulltext Access 10 Pages 2009
Hypoxia-inducible factor in cancer angiogenesis: Structure, regulation and clinical perspectives Fulltext Access 10 Pages 2009
Concomitant chemo-radiotherapy in clinical trials: To promote step by step rational development Fulltext Access 10 Pages 2009
Neurotropin reverses paclitaxel-induced neuropathy without affecting anti-tumour efficacy Fulltext Access 10 Pages 2009
Breast conserving treatment (BCT) for stage I-II breast cancer in elderly women: Analysis of 927 cases Fulltext Access 10 Pages 2009
Physiopathology and management of osteonecrosis of the jaws related to bisphosphonate therapy for malignant bone lesions. A French expert panel analysis Fulltext Access 10 Pages 2009
Identification of Raman spectroscopic markers for the characterization of normal and adenocarcinomatous colonic tissues Fulltext Access 10 Pages 2009
Incidence and clinical impact of chemotherapy induced myelotoxicity in cancer patients: An observational retrospective survey Fulltext Access 10 Pages 2009
Preclinical evaluation of vascular-disrupting agents in Ewing’s sarcoma family of tumours Fulltext Access 10 Pages 2009
Effect of the chronic combined administration of cisplatin and paclitaxel in a rat model of peripheral neurotoxicity Fulltext Access 10 Pages 2009
Febrile neutropenia and related complications in breast cancer patients receiving pegfilgrastim primary prophylaxis versus current practice neutropaenia management: Results from an integrated analysis Fulltext Access 10 Pages 2009
Predictors of the use of complementary and alternative medicine (CAM) by women at high risk for breast cancer Fulltext Access 10 Pages 2009
Cell division in the cerebral cortex of adult rats after photothrombotic ring stroke Fulltext Access 10 Pages 2009
Allogeneic Transplantation for Pediatric Acute Lymphoblastic Leukemia: The Emerging Role of Peritransplantation Minimal Residual Disease/Chimerism Monitoring and Novel Chemotherapeutic, Molecular, and Immune Approaches Aimed at Preventing Relapse Fulltext Access 10 Pages 2009
Effect of Conditioning Regimen Intensity on CMV Infection in Allogeneic Hematopoietic Cell Transplantation Fulltext Access 10 Pages 2009
Increase in FOXP3+ Regulatory T Cells in GVHD Skin Biopsies Is Associated with Lower Disease Severity and Treatment Response Fulltext Access 10 Pages 2009
Role of High-Dose Chemotherapy and Autologous Hematopoietic Cell Transplantation in Primary Systemic Amyloidosis: A Systematic Review Fulltext Access 10 Pages 2009
Thrombotic thrombocytopenia purpura (TTP) and other thrombotic microangiopathies Fulltext Access 10 Pages 2009
Role of reduced intensity transplant in adult patients with acute lymphoblastic leukemia: If and when? Fulltext Access 10 Pages 2009
MicroRNA expression profiling in acute myeloid and chronic lymphocytic leukaemias Fulltext Access 10 Pages 2009
Establishment and characterization of baboon embryonic stem cell lines: An Old World Primate model for regeneration and transplantation research Fulltext Access 10 Pages 2009
The therapeutic potential of bone marrow-derived mesenchymal stem cells on hepatic cirrhosis Fulltext Access 10 Pages 2009
Cluster characterization of mouse embryonic stem cell-derived pluripotent embryoid bodies in four distinct developmental stages Fulltext Access 10 Pages 2009
WHO/KFDA workshop on stability evaluation of vaccines, Seoul, Korea, 23–25 April 2008 Fulltext Access 10 Pages 2009
Vaccine stability study design and analysis to support product licensure Fulltext Access 10 Pages 2009
An improved abnormal toxicity test by using reference vaccine-specific body weight curves and histopathological data for monitoring vaccine quality and safety in Japan Fulltext Access 10 Pages 2009
The clinicopathological relevance of microRNA in normal and malignant haematopoiesis Fulltext Access 10 Pages 2009
Columnar cell lesions of the breast: an update and significance on core biopsy Fulltext Access 10 Pages 2009
Interferon Gamma 13-CA-Repeat Homozygous Genotype and a Low Proportion of CD4+ Lymphocytes Are Independent Risk Factors for Cytomegalovirus Reactivation with a High Number of Copies in Hematopoietic Stem Cell Transplantation Recipients Fulltext Access 10 Pages 2009
Is there under-treatment of pancreatic cancer? Evidence from a population-based study in Ireland Fulltext Access 10 Pages 2009
Bevacizumab in combination with paclitaxel for HER-2 negative metastatic breast cancer: An economic evaluation Fulltext Access 10 Pages 2009
Differential CD74 (major histocompatibility complex Class II invariant chain) expression in mouse and human intestinal adenomas Fulltext Access 10 Pages 2009
Applicability of staging systems for patients with hepatocellular carcinoma is dependent on treatment method – Analysis of 2010 Taiwanese patients Fulltext Access 10 Pages 2009
Are survival predictions reliable? Hospital volume versus standardisation of histopathologic reporting for accuracy of survival estimates after pancreatoduodenectomy for adenocarcinoma Fulltext Access 10 Pages 2009
Acute toxicity of curative radiotherapy for intermediate- and high-risk localised prostate cancer in the EORTC trial 22991 Fulltext Access 10 Pages 2009
Mitomycin C with continuous fluorouracil or with cisplatin in combination with radiotherapy for locally advanced anal cancer (European Organisation for Research and Treatment of Cancer phase II study 22011-40014) Fulltext Access 10 Pages 2009
The clinical efficacy of cytotoxic agents in locally advanced or metastatic breast cancer patients pretreated with an anthracycline and a taxane: A systematic review Fulltext Access 10 Pages 2009
CyclinD1 and interleukin-1 receptor antagonist polymorphisms are associated with prognosis in neoadjuvant-treated gastric carcinoma Fulltext Access 10 Pages 2009
Prevalence, socio-demographic and clinical predictors of post-diagnostic utilisation of different types of complementary and alternative medicine (CAM) in a nationwide cohort of Danish women treated for primary breast cancer Fulltext Access 10 Pages 2009
Oesophageal cancer in Golestan Province, a high-incidence area in northern Iran – A review Fulltext Access 10 Pages 2009
Resuscitation and transfusion principles for traumatic hemorrhagic shock Fulltext Access 10 Pages 2009
Current clinical and laboratory practice for the investigation of the antiphospholipid syndrome: findings from the 2008 Australasian antiphospholipid antibody survey Fulltext Access 10 Pages 2009
Receiving Information on Fertility- and Menopause-Related Treatment Effects among Women Who Undergo Hematopoietic Stem Cell Transplantation: Changes in Perceived Importance Over Time Fulltext Access 10 Pages 2009
Impact of Pre-transplant Rituximab on Survival after Autologous Hematopoietic Stem Cell Transplantation for Diffuse Large B Cell Lymphoma Fulltext Access 10 Pages 2009
Sequential Intensified Conditioning and Tapering of Prophylactic Immunosuppressants for Graft-versus-Host Disease in Allogeneic Hematopoietic Stem Cell Transplantation for Refractory Leukemia Fulltext Access 10 Pages 2009
Donor KIR3DL1/3DS1 Gene and Recipient Bw4 KIR Ligand as Prognostic Markers for Outcome in Unrelated Hematopoietic Stem Cell Transplantation Fulltext Access 10 Pages 2009
Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation in Metastatic Colorectal Cancer as a Novel Adoptive Cell Therapy Approach. The European Group for Blood and Marrow Transplantation Experience Fulltext Access 10 Pages 2009
Induction of Graft-versus-Leukemia (GVL) Effect without Graft-versus-Host Disease (GVHD) by Pretransplant Donor Treatment with Immunomodulators Fulltext Access 10 Pages 2009
Lung Function, Pulmonary Complications, and Mortality after Allogeneic Blood and Marrow Transplantation in Children Fulltext Access 10 Pages 2009
In Situ Activation and Expansion of Host Tregs: A New Approach to Enhance Donor Chimerism and Stable Engraftment in Major Histocompatibility Complex-Matched Allogeneic Hematopoietic Cell Transplantation Fulltext Access 10 Pages 2009
Costs of Hematopoietic Cell Transplantation: Comparison of Umbilical Cord Blood and Matched Related Donor Transplantation and the Impact of Posttransplant Complications Fulltext Access 10 Pages 2009
Unrelated Donor Hematopoietic Cell Transplantation for Non-Hodgkin Lymphoma: Long-Term Outcomes Fulltext Access 10 Pages 2009
The Release of Soluble Factors Contributing to Endothelial Activation and Damage after Hematopoietic Stem Cell Transplantation Is Not Limited to the Allogeneic Setting and Involves Several Pathogenic Mechanisms Fulltext Access 10 Pages 2009